healthcare
healthcare Articles
An FDA nod for NanoFlu, a recombinant quadrivalent seasonal influenza vaccine candidate, offered a boost to Novavax shares on Wednesday.
Published:
Organigram was one of the top stock market gainers on Wednesday after the cannabis and cannabis-derived products seller posted quarterly results.
Published:
When UnitedHealth reported mixed fourth-quarter financial results before the markets opened on Wednesday.
Published:
Some Americans believe that vaccinations are more dangerous than the diseases they prevent. The number is growing, says Gallup.
Published:
UnitedHealth is scheduled to report its most recent quarterly results before the opening bell on Wednesday.
Published:
Aquestive Therapeutics' shares lost nearly a third on Monday after the firm received an update from the FDA concerning its seizure treatment.
Published:
Adaptimmune shares absolutely exploded on Monday after the company announced encouraging responses for its Spear T-cell platform.
Published:
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
Published:
The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks increased.
Published:
Dermira shares made a handy gain to close out the week after it was announced that Eli Lilly would be acquiring the firm.
Published:
Applied Genetic Tech shares jumped by more than 50% on Thursday after the firm announced positive interim data from its midstage trial in X-linked retinitis pigmentosa.
Published:
DBV Tech shares jumped on Thursday after the firm announced positive topline results from its late-stage study in children with a peanut allergy.
Published:
Walgreens reported disappointing fiscal first-quarter financial results before the markets opened on Wednesday.
Published:
Xeris Pharmaceuticals shares pushed higher on Tuesday after the firm announced positive topline results from its midstage study in adults with Type 1 diabetes mellitus.
Published: